SCHEMBL3834348

SCHEMBL3834348

C[C@]1(c2ccc(Cl)cc2)NC(=S)N[C@H]1c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.42
ALDH1A1 P00352 3/20 0.38
GUSB P08236 1/20 0.36
HTT P42858 3/20 0.35
LMNA P02545 3/20 0.34
DRD2 P14416 1/20 0.34
KMT2A Q03164 5/20 0.34
ALOX12 P18054 2/20 0.34
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34
CHRNB4 P30926 1/20 0.34
SLC6A4 P31645 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CHRND Q07001 1/20 0.34
CNR1 P21554 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3834344 1.00 NPSR1 (0.42) NPSR1ALDH1A1GUSBHTTLMNA
SCHEMBL3873239 1.00 NPSR1 (0.42) NPSR1ALDH1A1GUSBHTTLMNA
SCHEMBL1508961 1.00 NPSR1 (0.42) NPSR1ALDH1A1GUSBHTTLMNA
SCHEMBL4204488 1.00 NPSR1 (0.42) NPSR1ALDH1A1GUSBHTTLMNA
SCHEMBL13567925 0.93 CNR1 (0.41) NPSR1ALDH1A1GUSBHTTLMNA
SCHEMBL13567928 0.93 CNR1 (0.41) NPSR1ALDH1A1GUSBHTTLMNA
SCHEMBL13568024 0.93 CNR1 (0.41) NPSR1ALDH1A1GUSBHTTLMNA
SCHEMBL13567903 0.93 CNR1 (0.41) NPSR1ALDH1A1GUSBHTTLMNA
SCHEMBL3827176 0.92 NPSR1 (0.45) NPSR1ALDH1A1GUSBLMNAKMT2A
SCHEMBL3847881 0.92 NPSR1 (0.48) NPSR1ALDH1A1LMNAKMT2AALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
EP-2103619-A1 IMIDAZOTHIAZOLE DERIVATIVES Daiichi Sankyo Company, Limited (JP) 2009-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312310-A1 Imidazothiazole derivatives TP53, MDM2, TP53BP1 NPSR1 4055/4885ALDH1A1 1990/4885GUSB 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.